NCCN Tumor Boards: Managing Unique Toxicities and IRAs in Hodgkin Lymphoma
NCCN will host a specialized tumor board session titled "Managing Unique Toxicities and Immune-Related Adverse Effects of Treatment for Hodgkin Lymphoma" on April 30, 2026, from 3:00 PM to 4:00 […]